Lilia-Celine (Lily) Lozada

Stock Analyst at J.P. Morgan

(1.73)
# 3,517
Out of 5,134 analysts
21
Total ratings
50%
Success rate
1.3%
Average return

Stocks Rated by Lilia-Celine (Lily) Lozada

NeuroPace
Nov 13, 2026
Downgraded: Hold
Price Target: $9
Current: $7.56
Upside: +19.05%
DENTSPLY SIRONA
Nov 6, 2026
Reiterated: Hold
Price Target: $12 → $10
Current: $9.16
Upside: +9.17%
Envista Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $32
Current: $24.49
Upside: +30.67%
AtriCure
Nov 4, 2026
Reiterated: Hold
Price Target: $36 → $62
Current: $56.84
Upside: +9.08%
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $5.27
Upside: n/a